India’s Natco Pharma, which just reported a substantial hit to its profits, today said it also has been issued a Form 483 for an API plant. More: Natco faces double whammy, falling profit and FDA plant violations Source: fierce
read moreU.S. Sens. Bernie Sanders and Elizabeth Warren have been harsh critics of the pharmaceutical industry in general. Now they’ve joined hands with three other senators to go after one pharma controversy in particular—Novartis, its AveXis unit and the manipulated data
read moreProfessor Helen Stokes-Lampard, chair of the Royal College of GPs said the figures are “deeply concerning”. More: Asthma deaths ‘highest this decade’ Source: News
read moreData from a new report show that the waiting times now exceed a fortnight, for the first time ever. More: Average GP waiting times now ‘exceed two weeks’ Source: News
read moreThe study is the first to compare Tremfya and the IL-17 inhibitor, Cosentyx. More: Tremfya tops Cosentyx in late-stage study Source: News
read moreVideo consultations have been cited as a way to take the strain off GPs. More: LIVI announces new NHS partnerships Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals